7508-26-1

Basic information

• Product Name: (5-phenylpentyl)propanedioic acid
• CAS NO: 7508-26-1
• Molecular Formula: C₁₄H₁₈O₄
• Molecular Weight: 250.2903
• Mol File: 7508-26-1.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 469.5°C at 760 mmHg
• Flash Point: 251.9°C
• Density: 1.186g/cm³
• Vapor Pressure: 1.28E-09mmHg at 25°C
• Refractive Index: 1.545
• CAS DataBase Reference: (5-phenylpentyl)propanedioic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (5-phenylpentyl)propanedioic acid(7508-26-1)
• EPA Substance Registry System: (5-phenylpentyl)propanedioic acid(7508-26-1)

Safety Data

• Hazardous Substances Data: 7508-26-1(Hazardous Substances Data)

Usage

Description

(5-phenylpentyl)propanedioic acid, also known as phenylpentylmalonic acid, is a chemical compound with the molecular formula C17H24O4. It is a dicarboxylic acid derivative, consisting of a propanedioic acid molecule with a 5-phenylpentyl group attached to one of the carbon atoms. This unique structure endows it with potential applications in various fields.

Uses

Used in Pharmaceutical Industry:
(5-phenylpentyl)propanedioic acid is used as a building block for the synthesis of various pharmaceuticals. Its unique structural properties make it a valuable component in the development of new drugs and medicinal compounds.
Used in Organic Synthesis:
(5-phenylpentyl)propanedioic acid is used as an intermediate in organic synthesis for the production of a wide range of organic compounds. Its versatility allows it to be incorporated into various chemical reactions, leading to the creation of diverse molecules.
Used in Material Science:
(5-phenylpentyl)propanedioic acid is used in material science for the development of new materials with specific properties. Its unique structure can contribute to the design and synthesis of advanced materials for various applications.

Upstream product

• 109398-68-7 toluene-4-sulphonic acid 5-phenyl-pentyl ester 
• 5454-06-8 3-phenylpropylmalonic acid 
• 34795-56-7 2-cyano-5-phenyl-pentanoic acid ethyl ester 
• 637-59-2 1-Bromo-3-phenylpropane 
• 2270-20-4 5-Phenylpentanoic acid 
• 10521-91-2 5-phenylpentan-1-ol 
• 1462-12-0 diethyl ethylidenemalonate 
• 15733-63-8 5-chloropentylbenzene 
• 1030-68-8 2-Cyan-7-phenyl-heptansaeure-aethylester 
• 78573-53-2 (5-phenyl-pentyl)-malonic acid diethyl ester 
• 7508-19-2 (5t-phenyl-penta-2t,4-dienylidene)-malonic acid 

Downstream Products

• 107416-06-8 7-phenyl-heptanoic acid amide 
• 40228-90-8 7-phenylheptanoic acid 

Relevant articles and documents

beta -thiopropionyl-aminoacid derivatives and their use as beta -lactamase inhibitors

PCT No. PCT/EP97/00516 Sec. 371 Date Jan. 13, 1999 Sec. 102(e) Date Jan. 13, 1999 PCT Filed Feb. 3, 1997 PCT Pub. No. WO97/30027 PCT Pub. Date Aug. 21, 1997A method of treatment of bacterial infections in humans or animals which comprises administering, in combination with a beta -lactam antibiotic, a therapeutically effective amount of an amino acid derivative of Formula (I) or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof, wherein: R is hydrogen, a salt forming cation or an in vivo hydrolysable ester-forming group; R1 is hydrogen, (C1-6)alkyl optionally substituted by up to three halogen atoms or by a mercapto, (C1-6)alkoxy, hydroxy, amino, nitro, carboxy, (C1-6)alkylcarbonyloxy, (C1-6)alkoxycarbonyl, formyl or (C1-6)alkylcarbonyl group, (C3-7)cycloalkyl, (C3-7)cycloalkyl(C2-6)alkyl, (C2-6)alkenyl, (C2-6)alkynyl, aryl, aryl(C1-6)alkyl, heterocyclyl or heterocyclyl(C1-6)alkyl; R2 is hydrogen, (C1-6)alkyl or aryl(C1-6)alkyl; R3 is hydrogen, (C1-6)alkyl optionally substituted by up to three halogen atoms, (C3-7)cycloalkyl, fused aryl(C3-7)cycloalkyl, (C3-7)cycloalkyl(C2-6)alkyl, (C2-6)alkenyl, (C2-6)alkynyl, aryl, aryl-(CHR10)m-X-(CHR11)n, heterocyclyl or heterocyclyl-(CHR10)m-X-(CHR11)n, where m is 0 to 3, n is 1 to 3, each R10 and R11 is independently hydrogen or (C1-4)alkyl and X is O, S(O)x where x is 0-2, or a bond; R4 is hydrogen, or an in vivo hydrolysable acyl group; and R5 and R6 are independently hydrogen and (C1-6)alkyl or together represent (CH2)p where p is 2 to 5. Some compounds are claimed per se.